Suchergebnisse - "Zhang, Liang"

PubPharm (7.511)

41

Safflower polysaccharide ameliorates acute ulcerative colitis by regulating STAT3/NF-κB signaling pathways and repairing intestinal barrier function

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Qi, M. | Chu, S. | Wang, W. | +10

42

Clinical status and perspective on the application of immunotherapy combined with chemotherapy in advanced non-small cell lung cancer : a review

enthalten in: Chinese clinical oncology | 2024

von Wang, T. | Zhang, L. | Cheng, Y.

43

Rapid establishment of municipal sewage partial denitrification-anammox for nitrogen removal through inoculation with side-stream anammox biofilm without domestication

enthalten in: Bioresource technology | 2024

von Yang, S. | Peng, Y. | Hou, F. | +5

44

Nécessaire pour le soin des matières kératineuses

enthalten in: Europäisches Patentamt | 2024

von HOU CHANGJIAN | LEE ZHENXI | ZHANG LIANG

45

Continuous production of ultratough semiconducting polymer fibers with high electronic performance

enthalten in: Science advances | 2024

von Zhang, Z. | Li, P. | Xiong, M. | +14

46

DBDNMF : A Dual Branch Deep Neural Matrix Factorization method for drug response prediction

enthalten in: PLoS computational biology | 2024

von Liu, H. | Wang, F. | Yu, J. | +4

47

Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium

enthalten in: Cardiovascular diabetology | 2024

von Sánchez-Ceinos, J. | Hussain, S. | Khan, A. | +4

48

Repressive H3K27me3 drives hyperglycemia-induced oxidative and inflammatory transcriptional programs in human endothelium

enthalten in: Cardiovascular diabetology | 2024

von Sánchez-Ceinos, J. | Hussain, S. | Khan, A. | +4

49

Increased Imaging Ligand Hydrophilicity and Improved Pharmacokinetic Properties Provides Enhanced In Vivo Targeting of Fibroblast Activation Protein

enthalten in: ResearchSquare.com | 2024

von Narain, R. | Nessler, I. | Richardson, P. | +8

50

ANTIBODY RESISTANT MODIFIED RECEPTORS TO ENHANCE CELL-BASED THERAPIES

enthalten in: Europäisches Patentamt | 2024

von MOORE MICHAEL | PANEA CASANDRA | SLEEMAN MATTHEW | +4